© Reuters. PHOTO: A nurse removes a Johnson & Johnson coronavirus (COVID-19) vaccine from a vial in Los Angeles.
(Reuters) – The U.S. government will allocate nearly 85% fewer Johnson & Johnson (NYSE 🙂 COVID-19 vaccines to states next week, data from the Centers for Disease Control and Prevention (CDC) showed.
Only 785,500 doses of J&J will be distributed, up from 4.95 million doses this week. The US Department of Health and Human Services (HHS) and J&J did not immediately respond to requests made after office hours to comment on the decline.
A New York Times report last week said workers at the Emergent BioSolutions facility in Baltimore, which produced both doses of AstraZeneca (NASDAQ 🙂 Plc and J&J, mixed the ingredients of the two vaccines, spoiling 15 million doses of J&J.
However, the Baltimore facility has not yet been sanctioned by the U.S. Food and Drug Administration, and a federal health official told Reuters last week that none of the doses of vaccine derived from the plant have yet been used in the effort. for vaccination.
J&J confirmed that it expects to deliver 100 million doses to the government by the end of May.
California is the top recipient of the J&J vaccine, followed by Texas and Florida, according to the CDC. Vaccine distribution for California has been cut by about 88%, with the state due to receive a maximum of 67,600 doses next week.
A California health spokesman told Reuters that the number will be even lower in the week of April 18, and the state will receive a total of 22,400 doses of J&J vaccine.
US President Joe Biden on Tuesday raised the target for the acceptability of the COVID-19 vaccine for all American adults to April 19.
Fusion media or any person associated with Fusion Media will not be held liable in any way for loss or damage arising from the use of information, including data, quotes, charts and buy / sell signals contained on this website. Be fully aware of the risks and costs associated with trading the financial markets, it is one of the most risky forms of investing.